Form 4: Repare Therapeutics EVP, CHIEF MEDICAL OFFICER Maria Koehler Reports Stock Sales to Cover Tax Obligations

Maria Koehler, EVP, CHIEF MEDICAL OFFICER of Repare Therapeutics Inc., reports selling common shares to cover tax obligations related to vested restricted stock units.

Summary

• Maria Koehler, the EVP, CHIEF MEDICAL OFFICER of Repare Therapeutics Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates sales of common shares on March 25, 2024, March 26, 2024, and March 27, 2024.
• These sales were executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) granted on January 30, 2023.
• A total of 1,500 shares were sold across the three days, with 500 shares sold each day.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on December 22, 2023.
• Following these transactions, Koehler still beneficially owns 232,209 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the stock sales are related to tax obligations and executed under a pre-arranged plan, indicating no discretionary selling based on the company's performance.

Industry Context

Executive stock sales to cover tax obligations upon RSU vesting are a common practice in publicly traded companies.

Stakeholder Impact

• The stock sales have a minimal impact on shareholders as they are related to tax obligations and executed under a pre-arranged plan.

Key Dates